Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) EGX:RMDA:
EGYPT'S RAMEDA Q1 NET PROFIT EGP 85.9 MILLION
EGYPT'S RAMEDA Q1 REVENUE EGP 865.6 MILLION
Egypt's Rameda Reports Q1 Profit EGP 85.9 Mln
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda on 6ix
Earlier from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
Later from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
- SNG: Egypt: Rameda reports 44.3% YoY consolidated profit decline in Q1 2025
- Egypt's Rameda Borad Proposes To Increase Issued Capital
- Egypt's Rameda Q3 Income EGP 96 Mln
- LVP Pharma Raises Stake In RAMEDA To 11.8% - EGX
- LVP Pharma Raises Stake In RAMEDA To 23.15% - EGX
Follow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda into a list and get an email when it puts out news.
Follow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda